š”š²šš š¦ššŗšŗš®šæš
ā¢ Prabhudas Lilladher has recommended a buy rating on Sun Pharmaceutical Industries with a target price of Rs 1280.
ā¢ Sun Pharma's Q2FY24 EBIDTA was in line with estimates, aided by domestic formulation and specialty sales.
ā¢ The company's growth is more focused on specialty, RoW, and domestic pharma business, with strong growth visibility.